We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Sunday
May 14
10:30 - 11:30
Plenary Hall
Genito-urinary
Daniel Matthias Aebersold, Switzerland;
Johannes Knoth, Austria
Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.
Proffered Papers
Clinical
10:30 - 10:40
Randomised phase II trial of adaptive image guided bladder radiotherapy: patient reported outcomes
Robert Huddart, United Kingdom
OC-0431
10:40 - 10:50
Patterns of Recurrence & Outcomes in Bladder Cancer Treated with Radiotherapy & Radiosensitisation
Taha Lodhi, United Kingdom
OC-0432
10:50 - 11:00
GETUG-AFU 22 phase II randomized trial : final results on clinical outcomes with immediate SRT
igor Latorzeff, France
OC-0433
11:00 - 11:10
Long -term results of OLIGOPELVIS, a Phase II Trial of pelvic RT in Oligorecurrent Prostate Cancer
Stephane Supiot, France
OC-0434
11:10 - 11:20
Multi-institutional nomogram for PSMA-PET based salvage radiotherapy in recurrent prostate cancer
Constantinos Zamboglou, Cyprus
OC-0435
11:20 - 11:30
A Delphi consensus study on SBRT for oligometastatic renal cell carcinoma (RCC) an ESTRO ACROP study
Giulia Marvaso, Italy
OC-0436